Curcumin Supplementation in Critically Ill Patients: A GRADE ‐Assessed Systematic Review and Meta‐Analysis of Randomized Controlled Trial
Phytotherapy Research · 2026-04 · 40 (4) · 2081-2097
DOI: 10.1002/ptr.70238 ↗At a glance
Metaanalyse in Phytotherapy Research, published online on 2026-02-06. Written by Seyyed Mostafa Arabi and 5 co-authors. Institution: Department of Clinical Nutrition and Biochemistry, Faculty of Medicine, Neyshabur University of Medical Sciences, Neyshabur, Razavi Khorasan, Iran. Major MEDLINE topics: Curcumin, Critical Illness, Dietary Supplements. Cited 2 times so far (Crossref); 67 references. Funded by: Neyshabur University of Medical Sciences.
Abstract (original language)
Curcuminoids are dietary polyphenols that can improve health indices through various mechanisms, such as anti‐inflammatory, antioxidant, and other clinical properties. Due to the lack of evidence on the efficacy of curcuminoids in critically ill patients, this meta‐analysis was conducted. The aim of this study was to assess and quantify the influence of curcumin supplementation on markers of inflammation, liver function, and clinical outcomes in critically ill patients. In this study, relevant randomized clinical trials were identified via electronic database searches, including MEDLINE, Scopus, and Web of Science, up until January 2025. The Cochrane risk‐of‐bias tool was utilized to assess the quality of the studies. Standardized mean differences (SMDs) and risk ratio (RR) in changes between intervention and placebo groups were calculated. Both random‐effects and fixed‐effects models were applied, and pre‐specified stratified analyses were performed to explore potential sources of heterogeneity. Out of a total of 691 studies screened, seven trials met the inclusion criteria, encompassing data from 571 participants. The pooled analysis demonstrated that curcumin supplementation significantly lowered alanine transaminase (ALT) levels (SMD: −0.4, 95% CI: −0.8 to −0.001, p = 0.03), total bilirubin levels (SMD: −0.4, 95% CI: −0.9 to −0.07, p = 0.01), Sequential Organ Failure Assessment (SOFA) scores (SMD: −0.8, 95% CI: −1.2 to −0.4, p < 0.001), the duration of intensive care unit (ICU) stays (SMD: −0.3 days, 95% CI: −0.6 to −0.1, p = 0.01), compared to placebo. Furthermore, curcumin supplementation was associated with significant increases in albumin (SMD: 0.3, 95% CI: 0.001 to 0.6, p = 0.004) and alkaline phosphatase levels (SMD: 0.4, 95% CI: 0.02 to 0.8, p = 0.01). This meta‐analysis demonstrates that curcumin supplementation improves liver function, albumin levels, SOFA scores, and ICU stay duration in critically ill patients, suggesting its potential role in mitigating organ dysfunction in this population.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- Department of Clinical Nutrition and Biochemistry, Faculty of Medicine, Neyshabur University of Medical Sciences, Neyshabur, Razavi Khorasan, Iran.
- Dezful Branch, Islamic Azad University, Dezful, Khuzestan, Iran.
- Department of Food Science and Nutrition, Faculty of Applied Sciences, UCSI University, Cheras, Kuala Lumpur, Malaysia.
- Faculty of Medicine, Navoi State University, Navoi, Razavi Khorasan, Uzbekistan.
- Center for Global Health Research, Saveetha Medical College and Hospitals, Saveetha Institute of Medical and Technical Sciences, Saveetha University, Chennai, Tamil Nadu, India.
- Biotechnology Research Center, Pharmaceutical Technology Institute, Mashhad University of Medical Sciences, Mashhad, Razavi Khorasan, Iran.
ORCID profiles: Amirhossein Sahebkar
Funding
- Neyshabur University of Medical Sciences
Cite
APA
Arabi, S. M., Mollahasni, A., Azarian, A., Chambari, M., Bahrami, L. S., & Sahebkar, A. (2026). Curcumin Supplementation in Critically Ill Patients: A GRADE ‐Assessed Systematic Review and Meta‐Analysis of Randomized Controlled Trial. Phytotherapy Research, 40(4), 2081-2097. https://doi.org/10.1002/ptr.70238
Vancouver
Arabi SM, Mollahasni A, Azarian A, Chambari M, Bahrami LS, Sahebkar A. Curcumin Supplementation in Critically Ill Patients: A GRADE ‐Assessed Systematic Review and Meta‐Analysis of Randomized Controlled Trial. Phytotherapy Research. 2026;40(4):2081-2097. doi:10.1002/ptr.70238
BibTeX
@article{Arabi2026,
author = {Arabi, Seyyed Mostafa and Mollahasni, Ali and Azarian, Abolfazl and Chambari, Mahla and Bahrami, Leila Sadat and Sahebkar, Amirhossein},
title = {Curcumin Supplementation in Critically Ill Patients: A GRADE ‐Assessed Systematic Review and Meta‐Analysis of Randomized Controlled Trial},
journal = {Phytotherapy Research},
year = {2026},
volume = {40},
number = {4},
pages = {2081--2097},
doi = {10.1002/ptr.70238}
}
EUVIMED